Now is good, earlier is better. by Tobert, J, Preiss, D

Lipid-modifying agents, from statins to PCSK9 inhibitors by Preiss, D, Tobert, J, Hovingh, G, Reith, C

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people. by Armitage, J, Bowman, L, Collins, R, Parish, S, Tobert, J

Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials by Clarke, R, Frost, C, Sherliker, P, Lewington, S, Collins, R, Brattstrom, L, Brouwer, I, van Dusseldorp, M, Steegers-Theunissen, R, Cuskelly, G, Ward, M, McNulty, H, Scott, J, den Heijer, M, Blom, H, van der Put, N, Shorah, C, Malinow, MR, McMahon, M, Tobert, J, Kush, D, Joosten, E, Riezier, R, Pietrzik, K, Dierkes, J

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease by Sammons, E, Hopewell, JC, Chen, F, Stevens, W, Wallendszus, K, Valdes-Marquez, E, Dayanandan, R, Knott, C, Murphy, K, Wincott, E, Baxter, A, Goodenough, R, Lay, M, Hill, M, Macdonnell, S, Fabbri, G, Lucci, D, Fajardo-Moser, M, Brenner, S, Hao, D, Zhang, H, Liu, J, Wuhan, B, Mosegaard, S, Herrington, W, Wanner, C, Angermann, C, Ertl, G, Maggioni, A, Barter, P, Mihaylova, B, Mitchel, Y, Blaustein, R, Goto, S, Tobert, J, DeLucca, P, Chen, Y, Chen, Z, Gray, A, Haynes, R, Armitage, J, Baigent, C, Wiviott, S, Cannon, C, Braunwald, E, Collins, R, Bowman, L, Landray, M